Institute of Physiology, University of Duisburg-Essen, 45122, Essen, Germany.
Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nuremberg, 91054, Erlangen, Germany.
Pflugers Arch. 2019 Dec;471(11-12):1343-1358. doi: 10.1007/s00424-019-02334-8. Epub 2019 Nov 22.
The recent bestowal of the Nobel Prize 2019 in Physiology or Medicine to Gregg L. Semenza, Sir Peter J. Ratcliffe, and William G. Kaelin Jr. celebrates a series of remarkable discoveries that span from the physiological research question on how oxygen deficiency (hypoxia) induces the red blood cell forming hormone erythropoietin (Epo) to the first clinical application of a novel family of Epo-inducing drugs to treat patients suffering from renal anemia. This review looks back at the most important findings made by the three Nobel laureates, highlights current research trends, and sheds an eye on future perspectives of hypoxia research, including emerging and potential clinical applications.
最近,格雷格·L·塞门扎(Gregg L. Semenza)、彼得·J·拉特克利夫爵士(Sir Peter J. Ratcliffe)和小威廉·G·凯林(William G. Kaelin Jr.)荣获 2019 年诺贝尔生理学或医学奖,这一殊荣表彰了一系列卓越的发现,涵盖了从氧气不足(缺氧)如何诱导红细胞生成素(Epo)这一生理学研究问题,到新型 Epo 诱导药物的首次临床应用,以治疗肾性贫血患者的过程。本文回顾了三位诺贝尔奖得主的最重要发现,突出了当前的研究趋势,并展望了未来的缺氧研究前景,包括新兴和潜在的临床应用。